pharmaphorum

JANUARY 4, 2021

Jennifer Haas, executive vice president of Noteworth, shares her 2021 predictions surrounding the future of telehealth and big data. . The ability to use big data in healthcare through digital medicine will prove to be invaluable for healthcare organisations as they work through the pandemic and the new world it has created.

Big Data 111

Big Data Medicine Doctor Doctors 111

Pharmaceutical Technology

FEBRUARY 16, 2023

Additional solutions include compression and friability testers, spectrophotometers, digital multimeters (DMMs), field measuring equipment, recorders, data loggers, resistance meters, power meters, signal generators, calibrators, probes, sensors, precision balances, and grips and fixtures.

Engineer 130

Engineer Manufacturing Containment Production 130

pharmaphorum

FEBRUARY 11, 2022

He oversees operations, including business development, sales and marketing, and people. He also serves as an executive advisor to Reify Health, Heads Up Health and other healthcare/healthtech startups focused on big data, SaaS, healthcare IT (HIT), and predictive analytics to improve patient outcomes.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

MAY 30, 2022

He oversees operations, including business development, sales and marketing, and people. He also serves as an executive advisor to Reify Health, Heads Up Health , and other healthcare/healthtech start-ups focused on big data, SaaS, healthcare IT (HIT), and predictive analytics to improve patient outcomes.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

Pharmaceutical Technology

FEBRUARY 15, 2023

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Big Data 130

Big Data Manufacturing Production Vaccination 130

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities.

Sales 98

Sales Manufacturing FDA Approval Life Science 98